NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MyulA.00654.a: Acetyl-CoA acetyltransferase FadA5

Target Characteristics

from organism: Mycobacterium ulcerans Agy99
most recent status: expressed
center reference id: MyulA.00654.a
is community request: False
associated disease: Buruli, Bairnsdale ulcer
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MyulA.00654.a.A1.GE29719 Full length( MyulA.00654.a ) 1 391 GE29719
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

External Resources

Resource Reference ID
OrthoMCL: NO_GROUP
PATRIC ID: fig|362242.7.peg.4771
RefSeq: YP_907624.1
UniProt: A0PUY4

Enzyme & Pathway Information

Pathway Pathway ID EC Number
acetoacetate degradation (to acetyl CoA) ACETOACETATE-DEG-PWY 2.3.1.9

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MGNPVIVEAT RSPIGKRNGW LSGLHATELL GAVQKALVHK AGLSSGLQPG DVEQVIGGCV TQFGEQSNNI SRVAWLTAGL PGHVGATTVD CQCGSGQQAN HLIAGLIAIG AIDIGIACGI EAMSRVGLGA NAGPDRSAIR AKSWDIDMPN QFEAAERIAK RRGITREDID AFGLESQLRA KRAWDEHRFD REISPIEAPV LDEQKQPTSE LHMVSRDQGL RDTTMAGLSE LKPVMEGGIH TAGTSSQISD GAAAVLWMDE EKARALGLRP RARIVSQALV GAEPYYHLDG PVQSTAKVLE KAGMKMGDID IVEINEAFAS VVLSWARVHE PEMAKVNVNG GAIALGHPVG CTGSRLITTA LHELERTDQS TALITMCAGG ALSTGTILER I

NT Sequence
ATGGGTAACC CGGTAATCGT AGAGGCGACG CGCAGTCCAA TCGGCAAGCG CAACGGATGG CTGTCAGGCC TGCACGCCAC CGAGTTGTTG GGGGCGGTTC AGAAGGCATT GGTGCACAAG GCCGGGCTCT CGTCGGGTCT ACAACCCGGA GATGTCGAAC AGGTCATCGG CGGTTGCGTG ACGCAGTTCG GGGAGCAGTC CAACAACATC AGCCGAGTGG CGTGGCTGAC CGCCGGCCTT CCCGGTCATG TCGGCGCCAC CACTGTCGAC TGCCAGTGCG GCAGCGGCCA GCAAGCCAAC CATTTGATCG CCGGCCTGAT CGCGATCGGG GCCATCGACA TCGGCATTGC CTGCGGGATC GAGGCGATGA GCCGGGTGGG CCTGGGCGCC AACGCCGGGC CGGACCGCTC CGCAATCCGG GCCAAGTCCT GGGACATCGA CATGCCGAAC CAGTTCGAGG CCGCCGAGCG CATCGCCAAG CGCCGCGGGA TCACCCGCGA AGACATCGAC GCGTTCGGAC TCGAATCCCA GTTGCGCGCC AAGCGCGCCT GGGACGAACA CCGCTTTGAT CGCGAAATCT CACCGATCGA GGCCCCAGTG CTCGATGAGC AGAAGCAGCC CACCAGCGAG CTGCACATGG TCTCTCGGGA CCAGGGTCTG CGCGACACCA CCATGGCGGG CTTGAGTGAG CTCAAGCCGG TAATGGAGGG CGGCATTCAC ACCGCGGGCA CGTCATCGCA GATTTCTGAC GGCGCGGCCG CCGTGTTGTG GATGGACGAG GAAAAGGCCA GGGCACTCGG TTTGCGCCCA CGCGCCCGCA TCGTCAGTCA GGCGCTCGTG GGCGCCGAGC CGTACTACCA CCTGGACGGG CCGGTGCAGT CGACGGCAAA GGTGCTCGAG AAGGCCGGGA TGAAGATGGG CGACATCGAC ATCGTGGAGA TCAACGAGGC TTTCGCATCG GTGGTGCTGT CCTGGGCGCG GGTTCACGAA CCCGAGATGG CCAAGGTCAA CGTCAACGGC GGCGCGATCG CCCTGGGCCA CCCGGTGGGA TGCACCGGCA GCCGGTTGAT CACCACCGCA CTGCACGAGC TGGAACGCAC CGACCAGAGC ACCGCGCTGA TCACCATGTG CGCGGGCGGA GCCCTGTCCA CCGGCACCAT TCTCGAGCGA ATC

© 2020 Seattle Children's Research Institute. All rights reserved.